Celldex Therapeutics (CLDX) Q3 2020 Earnings

6AugConfirmed
Q3 2019
Q4 2019
Q2 2020
Q3 2020
-1.17
-0.95
-0.72
-0.5

Details

Expected EPS
-0.57
Actual EPS
-0.5
Surprise EPS
0.07
Surprise Percent
+12.28%

Description

Celldex Therapeutics (CLDX) has reported earnings of -0.5 per share for Q3 2020.

0 Comments

Share your thoughts